Cargando…
Development of an engineered peptide antagonist against periostin to overcome doxorubicin resistance in breast cancer
BACKGROUND: Chemoresistance is one of the main problems in treatment of cancer. Periostin (PN) is a stromal protein which is mostly secreted from cancer associated fibroblasts in the tumor microenvironment and can promote cancer progression including cell survival, metastasis, and chemoresistance. T...
Autores principales: | Oo, Khine Kyaw, Kamolhan, Thanpawee, Soni, Anish, Thongchot, Suyanee, Mitrpant, Chalermchai, O-charoenrat, Pornchai, Thuwajit, Chanitra, Thuwajit, Peti |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7807878/ https://www.ncbi.nlm.nih.gov/pubmed/33446140 http://dx.doi.org/10.1186/s12885-020-07761-w |
Ejemplares similares
-
Periostin induces epithelial-to-mesenchymal transition via the integrin α5β1/TWIST-2 axis in cholangiocarcinoma
por: Sonongbua, Jumaporn, et al.
Publicado: (2020) -
Periostin regulates autophagy through integrin α5β1 or α6β4 and an AKT‐dependent pathway in colorectal cancer cell migration
por: Thongchot, Suyanee, et al.
Publicado: (2020) -
Breast cancer stem cell RNA-pulsed dendritic cells enhance tumor cell killing by effector T cells
por: Sumransub, Nuttavut, et al.
Publicado: (2020) -
Cancer-associated fibroblasts induce high mobility group box 1 and contribute to resistance to doxorubicin in breast cancer cells
por: Amornsupak, Kamolporn, et al.
Publicado: (2014) -
Nucleolin-based targeting strategies in cancer treatment: Focus on cancer immunotherapy (Review)
por: Thongchot, Suyanee, et al.
Publicado: (2023)